The 5th China International Import Expo (CIIE) saw Sanofi’s consumer healthcare unit announce a partnership with China Resources Sanjiu Medical & Pharmaceutical Co., Ltd (SHE: 000999). This collaboration marks a significant milestone in the companies’ ongoing efforts to enhance consumer healthcare in China.
Partnership History and Renewal
The two companies first partnered in 2016 regarding Essentiale forte N (phosphatidylcholine), a liver protection drug. Their contract has now been renewed for another 10 years, solidifying their long-term commitment to the Chinese market. Additionally, Sanofi launched the drug’s sister brand at the event, further expanding their product offerings.
Antiallergic Drug Introduction
On a related note, Sanofi also introduced its antiallergic drug Allegra into China. This move underscores the company’s strategy to broaden its portfolio and address diverse healthcare needs in the region.-Fineline Info & Tech
